Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news

PiF app
Latest News
Just the tonic for health brand
Business expansion behind name change
Bid to attract Covid vax trials
High-powered alliance in talks with vax makers
Aust not ready for RNA vax
Sigma in talks with government on cold challenges
Roche buys Aus/Irish start-up
Pays $617m upfront for inflammatory diseases company
Winners and losers in PBS fees
Some coming down, some going up and some new
Most Popular
AbbVie delays pain-free Humira
Asks for April 2021 PBS listing after thousands sign petition
Sigma turns away from PBS
Looks to other revenue streams to counter fall
Hunt hints at PBS Q4 listings
'Exciting pipeline' of new additions may shorten waitlist
Who's back in the office?
Exclusive: Sydney pharmas reveal Covid-safe plans
Face-to-face or virtual reps?
Two Aussie bosses argue their case for which is better
Novartis boss trips Down Under
Vas Narasimhan's virtual visit sidesteps border closures
'We can only afford one': RRDA
PBAC subs too costly for rare diseases company
BMS, Gilead build CAR-T teams
Prep for local cell-therapy MSAC subs, launch
MRFF funds three more vaxes
Takes local Aussie Covid candidates up to five
Hunt locked up... again
Quips about escaping 'People's Republic of Victoria'
Special Report
Aust Covid Vaccine Tracker
Live updates on frontrunners, local trials and deals
Approvals Action
Six pharmas add generics
Most copy PBS listed drugs
Top of the Hill
If only for a 2020 time machine
What would you do if you could start this year again?
Latest Jobs

Pharma in Focus  Jobs